Holen Sie sich die Stockscreener-App
1.43
0.70%
0.01
Handel nachbörslich:
1.45
0.02
+1.40%
Schlusskurs vom Vortag:
$1.42
Offen:
$1.41
24-Stunden-Volumen:
33,623
Relative Volume:
0.21
Marktkapitalisierung:
$7.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.91M
KGV:
-0.4387
EPS:
-3.26
Netto-Cashflow:
$-6.14M
1W Leistung:
-0.69%
1M Leistung:
-2.05%
6M Leistung:
+2.14%
1J Leistung:
-69.44%
1-Tages-Spanne:
$1.38
$1.44
1-Wochen-Bereich:
$1.35
$1.49
52-Wochen-Spanne:
$1.15
$4.81
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.43 | 7.78M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
Key metrics from Galmed Pharmaceuticals Ltd.’s quarterly dataJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com
What data driven models say about Galmed Pharmaceuticals Ltd.’s future2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock resilient in recession scenariosMarket Performance Report & Technical Pattern Recognition Alerts - newser.com
Multi factor analysis applied to Galmed Pharmaceuticals Ltd.Insider Buying & Breakout Confirmation Trade Signals - newser.com
How to track smart money flows in Galmed Pharmaceuticals Ltd.July 2025 Trade Ideas & Weekly High Conviction Trade Ideas - newser.com
Analyzing drawdowns of Galmed Pharmaceuticals Ltd. with statistical tools2025 Big Picture & Low Risk Entry Point Tips - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressuresWeekly Trend Summary & Fast Gaining Stock Strategy Reports - newser.com
Will Galmed Pharmaceuticals Ltd. benefit from macro trendsMarket Activity Report & Real-Time Stock Price Movement Reports - newser.com
What Fibonacci levels say about Galmed Pharmaceuticals Ltd. reboundEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Why Galmed Pharmaceuticals Ltd. stock remains on buy listsMarket Rally & Advanced Technical Signal Analysis - newser.com
Galmed Pharmaceuticals Ltd.’s volatility index tracking explainedIPO Watch & Target Return Focused Picks - newser.com
News impact scoring models applied to Galmed Pharmaceuticals Ltd.Portfolio Value Summary & Daily Volume Surge Signals - newser.com
Can you recover from losses in Galmed Pharmaceuticals Ltd.2025 Key Highlights & Community Verified Trade Alerts - newser.com
How to monitor Galmed Pharmaceuticals Ltd. with trend dashboardsPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by free cash flow2025 Major Catalysts & High Accuracy Investment Signals - nchmf.gov.vn
How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cutsGDP Growth & AI Based Trade Execution Alerts - nchmf.gov.vn
Aug EndMonth: Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by free cash flow2025 Major Catalysts & Free Long-Term Investment Growth Plans - Trung tâm Dự báo KTTV quốc gia
Options Flow: Is Galmed Pharmaceuticals Ltd. stock a top momentum playMarket Growth Report & Risk Adjusted Buy and Sell Alerts - nchmf.gov.vn
Published on: 2025-10-18 04:11:48 - nchmf.gov.vn
Galmed Pharmaceuticals Ltd.Ordinary Shares (NQ: GLMD - FinancialContent
Applying Elliott Wave Theory to Galmed Pharmaceuticals Ltd.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Understanding Galmed Pharmaceuticals Ltd.’s price movementWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Is Galmed Pharmaceuticals Ltd. a candidate for recovery playJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
What to do if you’re stuck in Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Portfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
What institutional flow reveals about Galmed Pharmaceuticals Ltd.2025 Price Targets & Community Consensus Picks - newser.com
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):